Combined treatment of schizophrenic psychoses with haloperidol and valproate

Pharmacopsychiatry

Volumn 31, Issue 4, 1998, Pages 122-125

  Dose, M ^a,f   Hellweg, R ^b   Yassouridis, A ^c   Theison, M ^d   Emrich, H M ^e  

^a Psychiatric District Hospital   (Germany)

^b FREIE UNIVERSITÄT BERLIN   (Germany)

^c MAX PLANCK INSTITUTE OF PSYCHIATRY   (Germany)

^d UNIVERSITY OF COLOGNE   (Germany)

^e HANNOVER MEDICAL SCHOOL   (Germany)

^f Psychiatrisches Bezirkskrankenhaus   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BIPERIDEN; CARBAMAZEPINE; CHLORPROTHIXENE; HALOPERIDOL; LIVER ENZYME; PLACEBO; VALPROIC ACID;

ADJUVANT THERAPY; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; EXTRAPYRAMIDAL SYMPTOM; FEMALE; HUMAN; MALE; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; PSYCHOSIS; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA;

EID: 0031686666     PISSN: 01763679     EISSN: None     Source Type: Journal    
DOI: 10.1055/s-2007-979312     Document Type: Article

References (22)

1. Altamura, A. C., M. C. Mauri, R. Cavallaro, A. Gorni: Haloperidol metabolism and antipsychotic effect in schizophrenia. Lancet 1 (1987) 814-815
2. rd ed. Washington, DC: American Psychiatric Press (1980)
3. Bowden, C. L., A. M. Brugger, A. C. Swann, J. R. Calabrese, P. G. Janicak, F. Petty, S. C. Dilsaver, J. M. Davis, A. J. Rush, J. G. Small, E. S. Garza-Trevino, S. C. Risch, P. J. Goodnick, D. D. Morris: Efficacy of Divalproex vs. Lithium and placebo in the treatment of Mania. J. Amer. Med. Ass. 271 (1994) 918-924
4. Dehing, J.: Studies on the psychotropic action of tegretol. Acta Neurol. Belg. 68 (1968) 895-905
5. Dose, M., S. Apelt, H. M. Emrich: Carbamazepine as an adjunct of antipsychotic therapy. Psychiatry Res. 22 (1987) 303-310
6. Emrich, H. M., T. Okuma, A. A. Müller: Anticonvulsants in affective disorders. Excerpta Medica, Amsterdam (1984)
7. Emrich, H. M., M. Dose, D. von Zerssen: The use of sodium valproate, carbamazepine, and oxcarbazepine in patients with affective disorders. J. Affect Disord. 8 (1985) 243-250
8. Ereshefsky, L., Ch. D. Davis, Ch. A. Harrington, M. W. Jann, J. L. Browning, St. R. Sakland, N. R. Burch: Haloperidol and reduced haloperidol plasma levels in selected schizophrenic patients. J. Clin. Psychopharmacol. 4 (1984) 138-142
9. Fast, D. K., B. D. Jones, M. Kusalic, M. Erickson: Effect of carbamazepine on neuroleptic plasma levels and efficacy. Amer. J. Psychiatry 143 (1986) 117-118
10. Hakola, H. P. A., V. A. Laulumaa: Carbamazepine in treatment of violent schizophrenics. Lancet 12 (1992) 1358
11. Johannessen, S. J., O. Henricksen: Pharmacokinetic observations of sodium valproate in healthy subjects and in patients with epilepsy. In: Johannessen, S. J., P. L. Morselli, C. E. Pippenger, A. Richens, D. Schmidt, H. Meinardi (eds.): Antiepileptic therapy: Advances in plain drug monitoring. New York: Raven Press (1980) 131-140
12. Kapetanovic, J., H. J. Kupferberg, R. J. Porter, J. K. Penry: Valproic acid-phenobarbital interaction: A systematic study using stable isotopically labelled phenobarbital in an epileptic patient. In: Johannessen, S. J., P. L. Moreselli, C. E. Pippenger, A. Richens, D. Schmidt, H. Meinardi (eds.): Antiepileptic therapy: Advances in plain drug monitoring. Raven Press, New York (1980) 373-381
13. Klein, E., E. Bental, B. Lerer, R. H. Belmaker: Carbamazepine and haloperidol vs. placebo and haloperidol in excited psychoses. Arch. Gen. Psychiatry 41 (1984) 165-170
14. Ko, G. N., E. R. Korpi, W. J. Freed, S. J. Zalcman, L. B. Bigelow: Effects of valproic acid on behaviour and plasma amino acid concentrationsin chronic schizophrenic patients. Biol. Psychiatry 20 (1985) 209-215
15. Linnoila, M., M. Viukari, O. Hietala: Effect of sodium valproate on tardive dyskinesia. Brit. J. Psychiatry 129 (1976) 114-119
16. Lorr, M., D. M. McNair, C. J. Klett, J. J. Lasky: Evidence of ten psychotic syndromes. J. Consult Clin. Psychol. 26 (1962) 185
17. McElroy, S. L., P. E. Keck, H. G. Pope: Sodium valproate: Its use in primary psychiatric disorders. J. Clin. Psychopharmacol. 7 (1987) 16-24
18. Müller-Oerlinghausen, B., A. Retzow: Valproate as an adjunct to neuroleptic medication in the treatment of acute manic episodes. Pharmacopsychiat. 30 (1997) 202
19. Nagao, T., T. Ohshimo, K. Mitsunobu, M. Sato, S. Otsuki: Cerebrospinal fluid monoamine metabolites and cyclic nucleotides in chronic schizophrenic patients with tardive dyskinesia or drug-induced tremor. Biol. Psychiatry 14 (1979) 509-523
20. Neppe, V. M.: Carbamazepine as adjunctive treatment in non-epileptic chronic inpatients with EEG temporal lobe abnormalities. J. Clin. Psychiatry 44 (1983) 326-331
21. Overall, J. E., D. R. Gorham: The Brief Psychiatric rating Scale. Psychol. Rev. 10 (1962) 799-812
22. Simpson, G. M., J. W. S. Angus: A rating scale for extrapyramidal side effects. Acta Psychiatr. Scand., (Suppl.) 212 (1970) 11-19